Clinical Trials Directory

Trials / Terminated

TerminatedNCT03614507

Automation Oxygen Flow Titration in Spontaneously Breathing Infants

Automation Oxygen Flow Titration in Spontaneously Breathing Infants Less Than One Year of Age During a First Episode of Bronchiolitis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
1 Month – 1 Year
Healthy volunteers
Not accepted

Summary

The objective of this study is to assess the efficacy of the FreeO2 device in shortening the hospital length of stay during a first episode of hypoxemic bronchiolitis in infants less than 1 year of age. FreeO2Bronchio study is a multicenter, prospective, controlled, randomized, open-label study.

Detailed description

This is a controlled, randomized, open-label, multicentre trial. Patients will be included after written informed consent will be obtained from the patients' parents or legally authorized representatives. Patients will be randomized either in the "FreeO2" group for automatic oxygen flow titration or in the "manual" group for Oxygen therapy with manual flow titration. The SpO2 will be recorded continuously in both groups of the study using the FreeO2 device throughout the duration of hospitalization; In the group "FreeO2 ", the device will record the data continuously and allow the automation of oxygen titration - in the group "Manual", the device will only be used to monitor SpO2 and heart rate.

Conditions

Interventions

TypeNameDescription
DEVICEFreeO2 (modèle FO2-220-00) automatic oxygen flow titrationAutomatic adjustment of oxygen flow titration through the FreeO2 device. The monitor allows continuous monitoring and recording of SpO2 and Heart rate
DEVICEFreeO2 (modèle FO2-220-00) manual oxygen flow titrationManual oxygen flow titration performed by the healthcare provider in charge of the patient (nurse, physician). For this group, the FreeO2 device will only monitor and record SpO2 and heart rate.

Timeline

Start date
2018-10-09
Primary completion
2023-07-05
Completion
2023-07-05
First posted
2018-08-03
Last updated
2024-12-17

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03614507. Inclusion in this directory is not an endorsement.